Losartan Sandoz 50 mg - Filmtabletten

Recall | Medicines | 21/09/2021

The marketing authorisation holder informed its customers on September 21, 2021 that laboratory analyses of the active ingredient used in the mentioned batches have revealed azido contamination above the acceptable limit.

For this reason, the affected batches are recalled.

Name of the medicinal product Losartan Sandoz 50 mg - Filmtabletten
Marketing authorisation number(s) 1-27047
CIP code 3515905
Marketing authorisation holder Sandoz GmbH
Batch number(s) batches, expiry date
KC 2277, 07.2022
KM5233, 02.2023
KZ9888, 03.2023
KZ9889, 03.2023
Classification of the recall2
Depth of recall Pharmacies
BASG reference number INS-640.001-3634

Further inquiry note